Nutriband (NASDAQ:NTRB - Get Free Report) released its earnings results on Friday. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.01, Zacks reports. The company had revenue of $0.67 million for the quarter, compared to the consensus estimate of $0.71 million. Nutriband had a negative net margin of 338.51% and a negative return on equity of 54.49%.
Nutriband Stock Performance
Shares of NTRB traded down $0.24 during trading hours on Friday, reaching $6.22. 27,564 shares of the company traded hands, compared to its average volume of 77,664. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01. The business has a fifty day moving average price of $5.62 and a 200-day moving average price of $5.70. Nutriband has a 12-month low of $3.72 and a 12-month high of $11.78. The stock has a market capitalization of $69.38 million, a P/E ratio of -8.76 and a beta of 1.18.
Nutriband Company Profile
(
Get Free Report)
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Further Reading
Before you consider Nutriband, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutriband wasn't on the list.
While Nutriband currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
